Indoco Remedies Limited
Nippon India Mutual Fund lowered its stake in Indoco Remedies from 4.80% to 4.63%, reducing its holding from 44.29 lakh to 42.74 lakh shares. This decrease occurred in the context of a rights issue.
A Mumbai-based pharmaceutical company engaged in manufacturing and marketing finished dosage formulations and active pharmaceutical ingredients for domestic and international markets. Indoco Remedies operates across formulations, contract manufacturing, and research divisions, maintaining vertically integrated operations spanning drug development, manufacturing, and distribution. The company serves healthcare providers and patients through its diverse pharmaceutical portfolio and specialized manufacturing capabilities.
India's fifth-largest AMC with over Rs 6 lakh crore in AUM, backed by Japan's Nippon Life Insurance which holds majority stake. Formerly Reliance MF, rebranded in 2019 after Nippon's acquisition. Sailesh Raj Bhan has run the equity book for over two decades and is one of India's most experienced active managers. Known for sector rotational calls and a deep research bench.